Eloxx Pharmaceuticals, Inc. (ELOX)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Between 2026-08-02 and 2026-10-31, public records show 1 signal for Eloxx Pharmaceuticals, Inc.. Most notable: 2026-10-22: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-10-31 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-10Domicilium Real Estate Fund III LPten percent ownerJ361,578——
2026-06-10Domicilium Real Estate Fund III LPten percent ownerJ238,422——
2026-05-27Domicilium Real Estate Fund III LPten percent ownerJ113,6360$0
2026-05-27Coastlands Capital LPten percent ownerJ1,250,0000$0
2026-02-28Aggarwal SumitdirectorM260,9460.15$39,142
2026-01-24Rubin Steven DdirectorM1,875——
2026-01-24Aggarwal SumitdirectorM15,000——
2026-01-24Walts Alan EdmunddirectorM1,875——
2025-09-19Aggarwal SumitdirectorA1,000,0000$0
2025-08-14Aggarwal SumitdirectorM196,8800$0
2025-01-24Aggarwal SumitdirectorM30,0000$0
2025-01-24Rubin Steven DdirectorM3,7500$0
2025-01-24Androski LindsaydirectorM3,7500$0
2025-01-24Walts Alan EdmunddirectorM3,7500$0
2024-10-16Walts Alan EdmunddirectorA12,0000$0
2024-10-16Androski LindsaydirectorA12,0000$0
2024-10-16Rubin Steven DdirectorA12,0000$0
2024-10-16Aggarwal SumitdirectorA165,0000$0

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings